TXG
10x Genomics, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$76.60
−0.48%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.27
- Revenue estimate
- $147.3M
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- -$0.14
- EPS estimate
- -$0.24
- Revenue actual
- $151.0M
- Revenue estimate
- $146.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -18.7%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $53
- PT range
- $40 – $70
- Analysts
- 10
4 Buy6 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | -$0.24 | -$0.14 | Beat 42.41% | $151.0M |
| May 7, 2026 | -$0.29 | -$0.10 | Beat 65.52% | $150.8M |
| Feb 12, 2026 | -$0.19 | -$0.13 | Beat 31.58% | $166.0M |
| Nov 6, 2025 | -$0.07 | -$0.22 | Miss -214.29% | $149.0M |
| Aug 7, 2025 | -$0.35 | $0.28 | Beat 180.00% | $172.9M |
| May 8, 2025 | -$0.45 | -$0.36 | Beat 20.00% | $154.9M |
| Feb 12, 2025 | -$0.29 | -$0.40 | Miss -37.93% | $165.0M |
| Aug 8, 2024 | -$0.47 | -$0.32 | Beat 31.91% | $153.1M |
| Apr 30, 2024 | -$0.46 | -$0.50 | Miss -8.70% | $141.0M |
| Feb 15, 2024 | -$0.36 | -$0.41 | Miss -13.89% | $184.0M |
| Nov 2, 2023 | -$0.45 | -$0.51 | Miss -13.33% | $153.6M |
| Aug 3, 2023 | -$0.39 | -$0.53 | Miss -35.90% | $146.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026